{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:32:06Z","timestamp":1787776326182,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    We describe the case of a 72-year-old male with a history of systemic mastocytosis scheduled for on-pump aortic valve replacement for severe aortic insufficiency. Anesthesia and peri-operative management included avoidance of histamine-releasing drugs, methylprednisolone and clemastin prophylaxis. Furthermore, a CytoSorb\n                    <jats:sup>\u00ae<\/jats:sup>\n                    cartridge has been added to the bypass circuit and hemoadsorption was performed throughout the entire cardiopulmonary bypass (CPB) duration. CytoSorb\n                    <jats:sup>\u00ae<\/jats:sup>\n                    is a hemoadsorption device designed to remove various cytokines and drugs from the blood. The use of CytoSorb\n                    <jats:sup>\u00ae<\/jats:sup>\n                    during CPB in our case was not associated with adverse events, and the patient did not present any allergic or anaphylactic reaction.\n                  <\/jats:p>","DOI":"10.4103\/aca.aca_16_24","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T07:16:18Z","timestamp":1724915778000},"page":"364-367","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Mastocytosis Successfully Managed using Cytosorb\u00ae During Cardiopulmonary Bypass for Aortic Valve Replacement"],"prefix":"10.4103","volume":"27","author":[{"given":"Adrien","family":"Gross","sequence":"first","affiliation":[{"name":"Department of Anaesthesia, ICH, Valais Hospital, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Colombier","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, ICH, Valais Hospital, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Arlettaz","sequence":"additional","affiliation":[{"name":"Department of Service of Immunology and Allergology, ICH, Valais Hospital, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Delay","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, ICH, Valais Hospital, Sion, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"R1-20241226","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajh.26118","article-title":"Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management","volume":"96","author":"Pardanani","year":"2021","journal-title":"Am J Hematol"},{"key":"R2-20241226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ad.2015.09.009","article-title":"Update on mastocytosis (Part 2): Categories, prognosis, and treatment","volume":"107","author":"Aza\u00f1a","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"R3-20241226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ad.2015.09.007","article-title":"Update on mastocytosis (Part 1): Pathophysiology, clinical features, and diagnosis","volume":"107","author":"Aza\u00f1a","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"R4-20241226","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31817e6d7c","article-title":"Pediatric mastocytosis: Routine anesthetic management for a complex disease","volume":"107","author":"Carter","year":"2008","journal-title":"Anesth Analg"},{"key":"R5-20241226","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2044.1998.00536.x","article-title":"Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia","volume":"53","author":"Vaughan","year":"1998","journal-title":"Anaesthesia"},{"key":"R6-20241226","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/ALN.0000000000000031","article-title":"Perioperative management of patients with mastocytosis","volume":"120","author":"Dewachter","year":"2014","journal-title":"Anesthesiology"},{"key":"R7-20241226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1540-8191.2011.01404.x","article-title":"Aortic valve replacement in patients with systemic mastocytosis","volume":"27","author":"Wanamaker","year":"2012","journal-title":"J Card Surg"},{"key":"R8-20241226","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2017.07.022","article-title":"Management around invasive procedures in mastocytosis: An update","volume":"119","author":"Hermans","year":"2017","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"key":"R9-20241226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/000313480907500115","article-title":"Guidelines for safe surgery in patients with systemic mastocytosis","volume":"75","author":"Chaar","year":"2009","journal-title":"Am Surg"},{"key":"R10-20241226","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/jcm12031156","article-title":"A practical approach to systemic mastocytosis complications in cardiac surgery: A case report and systematic review of the literature","volume":"12","author":"Suleiman","year":"2023","journal-title":"J Clin Med"},{"key":"R11-20241226","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijsu.2005.04.002","article-title":"The systemic inflammatory response syndrome and cardiopulmonary bypass","volume":"3","author":"Day","year":"2005","journal-title":"Int J Surg Lond Engl"},{"key":"R12-20241226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1010-7940(01)01099-5","article-title":"Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update","volume":"21","author":"Paparella","year":"2002","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"R13-20241226","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.3390\/jcm11216407","article-title":"Vasoplegic syndrome after cardiopulmonary bypass in cardiovascular surgery: Pathophysiology and management in critical care","volume":"11","author":"Ltaief","year":"2022","journal-title":"J Clin Med"},{"key":"R14-20241226","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5301\/ijao.5000492","article-title":"Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: A case series","volume":"39","author":"Tr\u00e4ger","year":"2016","journal-title":"Int J Artif Organs"},{"key":"R15-20241226","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13054-019-2399-4","article-title":"Cytokine clearance with CytoSorb\u00ae during cardiac surgery: A pilot randomized controlled trial","volume":"23","author":"Poli","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"R16-20241226","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.CCM.0000114997.39857.69","article-title":"Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia","volume":"32","author":"Kellum","year":"2004","journal-title":"Crit Care Med"},{"key":"R17-20241226","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-018-5464-6","article-title":"Hemoadsorption with CytoSorb\u00ae","volume":"45","author":"Poli","year":"2019","journal-title":"Intensive Care Med"},{"key":"R18-20241226","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0267659120967827","article-title":"Cytosorb\u00ae hemoadsorption of apixaban during emergent cardio-pulmonary bypass: A case report","volume":"36","author":"Mendes","year":"2021","journal-title":"Perfusion"},{"key":"R19-20241226","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"R20-20241226","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13054-016-1270-0","article-title":"Effect of hemoadsorption during cardiopulmonary bypass surgery - A blinded, randomized, controlled pilot study using a novel adsorbent","volume":"20","author":"Bernardi","year":"2016","journal-title":"Crit Care Lond Engl"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_16_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:06:32Z","timestamp":1787774792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_16_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_16_24","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"2024-01-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}